Cargando…
Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now?
Resistance to antibiotic treatment developed by bacteria in humans and animals occurs when the microorganisms resist treatment with clinically approved antibiotics. Actions must be implemented to stop the further development of antibiotic resistance and the subsequent emergence of superbugs. Medicat...
Autores principales: | Nocentini, Alessio, Capasso, Clemente, Supuran, Claudiu T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854953/ https://www.ncbi.nlm.nih.gov/pubmed/36671343 http://dx.doi.org/10.3390/antibiotics12010142 |
Ejemplares similares
-
An overview on the recently discovered iota-carbonic anhydrases
por: Nocentini, Alessio, et al.
Publicado: (2021) -
Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII
por: Giovannuzzi, Simone, et al.
Publicado: (2022) -
Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii
por: Del Prete, Sonia, et al.
Publicado: (2020) -
Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors
por: Rogato, Alessandra, et al.
Publicado: (2019) -
Coumarins inhibit η-class carbonic anhydrase from Plasmodium falciparum
por: Giovannuzzi, Simone, et al.
Publicado: (2022)